Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis

Affiliations


Abstract

The HLH-2004 criteria are used to diagnose hemophagocytic lymphohistiocytosis (HLH), yet concern exists for their misapplication, resulting in suboptimal treatment of some patients. We sought to define the genomic spectrum and associated outcomes of a diverse cohort of children who met the HLH-2004 criteria. Genetic testing was performed clinically or through research-based whole-exome sequencing. Clinical metrics were analyzed with respect to genomic results. Of 122 subjects enrolled over the course of 17 years, 101 subjects received genetic testing. Biallelic familial HLH (fHLH) gene defects were identified in only 19 (19%) and correlated with presentation at younger than 1 year of age (P < .0001). Digenic fHLH variants were observed but lacked statistical support for disease association. In 28 (58%) of 48 subjects, research whole-exome sequencing analyses successfully identified likely molecular explanations, including underlying primary immunodeficiency diseases, dysregulated immune activation and proliferation disorders, and potentially novel genetic conditions. Two-thirds of patients identified by the HLH-2004 criteria had underlying etiologies for HLH, including genetic defects, autoimmunity, and malignancy. Overall survival was 45%, and increased mortality correlated with HLH triggered by infection or malignancy (P < .05). Differences in survival did not correlate with genetic profile or extent of therapy. HLH should be conceptualized as a phenotype of critical illness characterized by toxic activation of immune cells from different underlying mechanisms. In most patients with HLH, targeted sequencing of fHLH genes remains insufficient for identifying pathogenic mechanisms. Whole-exome sequencing, however, may identify specific therapeutic opportunities and affect hematopoietic stem cell transplantation options for these patients.

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests.


Figures


Similar articles

Targeted high-throughput sequencing for genetic diagnostics of hemophagocytic lymphohistiocytosis.

Tesi B, Lagerstedt-Robinson K, Chiang SC, Ben Bdira E, Abboud M, Belen B, Devecioglu O, Fadoo Z, Yeoh AE, Erichsen HC, Möttönen M, Akar HH, Hästbacka J, Kaya Z, Nunes S, Patiroglu T, Sabel M, Saribeyoglu ET, Tvedt TH, Unal E, Unal S, Unuvar A, Meeths M, Henter JI, Nordenskjöld M, Bryceson YT.Genome Med. 2015 Dec 18;7:130. doi: 10.1186/s13073-015-0244-1.PMID: 26684649 Free PMC article.

Digenic Inheritance: Evidence and Gaps in Hemophagocytic Lymphohistiocytosis.

Steen EA, Hermiston ML, Nichols KE, Meyer LK.Front Immunol. 2021 Nov 17;12:777851. doi: 10.3389/fimmu.2021.777851. eCollection 2021.PMID: 34868048 Free PMC article. Review.

Clinical features, genetics, and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in Korea: report of a nationwide survey from Korea Histiocytosis Working Party.

Koh KN, Im HJ, Chung NG, Cho B, Kang HJ, Shin HY, Lyu CJ, Yoo KH, Koo HH, Kim HJ, Baek HJ, Kook H, Yoon HS, Lim YT, Kim HS, Ryu KH, Seo JJ; Korea Histiocytosis Working Party.Eur J Haematol. 2015 Jan;94(1):51-9. doi: 10.1111/ejh.12399. Epub 2014 Jul 3.PMID: 24935083 Free PMC article.

Pathogenic Gene Mutations or Variants Identified by Targeted Gene Sequencing in Adults With Hemophagocytic Lymphohistiocytosis.

Miao Y, Zhu HY, Qiao C, Xia Y, Kong Y, Zou YX, Miao YQ, Chen X, Cao L, Wu W, Liang JH, Wu JZ, Wang L, Fan L, Xu W, Li JY.Front Immunol. 2019 Mar 7;10:395. doi: 10.3389/fimmu.2019.00395. eCollection 2019.PMID: 30899265 Free PMC article.

Familial and acquired hemophagocytic lymphohistiocytosis.

Janka GE.Eur J Pediatr. 2007 Feb;166(2):95-109. doi: 10.1007/s00431-006-0258-1. Epub 2006 Dec 7.PMID: 17151879 Review.


Cited by

Inborn Error of STAT2-Dependent IFN-I Immunity in a Patient Presented with Hemophagocytic Lymphohistiocytosis and Multisystem Inflammatory Syndrome in Children.

López-Nevado M, Sevilla J, Almendro-Vázquez P, Gil-Etayo FJ, Garcinuño S, Serrano-Hernández A, Paz-Artal E, González-Granado LI, Allende LM.J Clin Immunol. 2023 Apr 19:1-11. doi: 10.1007/s10875-023-01488-6. Online ahead of print.PMID: 37074537 Free PMC article.

The Multifaceted Immunology of Cytokine Storm Syndrome.

Lee PY, Cron RQ.J Immunol. 2023 Apr 15;210(8):1015-1024. doi: 10.4049/jimmunol.2200808.PMID: 37011407 Review.

Diagnosis and Management of Adult Malignancy-Associated Hemophagocytic Lymphohistiocytosis.

Lee JC, Logan AC.Cancers (Basel). 2023 Mar 18;15(6):1839. doi: 10.3390/cancers15061839.PMID: 36980725 Free PMC article. Review.

Traffic jam within lymphocytes: A clinician's perspective.

Hosahalli Vasanna S, Dalal J.Front Immunol. 2023 Jan 16;13:1034317. doi: 10.3389/fimmu.2022.1034317. eCollection 2022.PMID: 36726976 Free PMC article. Review.

Precision medicine: The use of tailored therapy in primary immunodeficiencies.

Pinto MV, Neves JF.Front Immunol. 2022 Dec 8;13:1029560. doi: 10.3389/fimmu.2022.1029560. eCollection 2022.PMID: 36569887 Free PMC article. Review.


KMEL References